Overview

When private equity firms pursue life sciences industry targets, attorney Amy Dow provides a clear picture of the potential regulatory and compliance impacts of their investments. Investors appreciate Amy’s measured approach to addressing risk and her ability to explain challenges in a commercial context.

She quickly assembles multidisciplinary teams of lawyers and technical advisors to provide a complete view of a target company’s regulatory risk profile, including existing investigations and enforcement, FDA inspection history, quality and compliance obligations, data privacy and security practices, and litigation risk. Whether she’s advising on a current regulatory enforcement action or recommending post-acquisition compliance program enhancements, Amy tailors solutions to her clients' risk tolerance and investment objectives.

Pharmaceutical, biotechnology, and medical device companies regularly call on Amy’s counsel to support development and commercialization of their products. Her practical advice helps development-stage companies intensify their compliance efforts as they expand their operations, develop promotional strategies, and launch sales teams. Amy frequently helps non-U.S. companies entering the U.S. market to prepare for heightened compliance expectations, tough regulatory scrutiny of their drug and medical device products and the U.S. reimbursement environment. For established companies, she leads teams of lawyers and former in-house compliance officers who assess their existing compliance programs, spot weaknesses, and implement strategies to mitigate future risks. Sponsors, contract research organizations, and clinical research services providers also rely on her advice when structuring relationships for product development and clinical research services.

Read more

Amy serves as a member of the firm’s Board of Directors and as a Chair of Epstein Becker Green’s National Health Care & Life Sciences Steering Committee. Before she became a lawyer, Amy worked for five years as a senior clinical research associate at a large contract research organization, where she monitored pharmaceutical clinical trials and led regulatory compliance training programs. A graduate of the University of Arizona, Amy received a Bachelor of Science, magna cum laude, in microbiology.

Read less

Focus Areas

Experience

View All Experience
  • Advised a development-stage pharmaceutical manufacturer launching its first offering—a novel cellular therapy designated as a “Breakthrough Therapy” by the U.S. Food and Drug Administration (“FDA”)—in coordination with its global pharmaceutical manufacturer commercialization partner. Amy provided health regulatory counsel for negotiations with U.S. and global research providers and guided the expansion of the company’s corporate compliance, medical affairs and commercial operations, and scientific and commercial communications programs.
  • Provided health regulatory counsel to a molecular diagnostic laboratory with a proprietary next-generation sequencing platform enabling molecular profiling of cancer patients’ tumor tissue. Having represented the client since its inception, Amy leads a team that provides health care regulatory and compliance support, privacy advice and negotiation of research collaboration partnerships.
  • Supported a contract research organization’s post-transaction integration efforts, including developing enhancements to its customer and vendor contracting practices and templates for use by its U.S. and global affiliates.
  • Served as U.S. regulatory counsel to a private equity firm in the proposed acquisition of a global radiopharmaceutical manufacturer and distributor. Amy led a cross-functional team of regulatory counsel and consulting resources to assess the target’s product development pipeline and the current FDA regulatory landscape for biopharmaceuticals. The team also analyzed the U.S. reimbursement landscape for certain target products and advised on remediation of recent regulatory authority actions.

Recognition

  • Chambers USA: America’s Leading Lawyers for Business: Illinois—Healthcare, "Leader in Their Field" (2020); Illinois—Healthcare: Pharmaceutical/Medical Products Regulatory, "Leader in Their Field" (2021 to 2024)
  • The Legal 500 United States: M&A: Middle Market (Sub-$500 Million) (2014 to 2019, 2021 to 2024);

    Healthcare: Health Insurers (2024)

  • Crain's Chicago Business: Notable Women in Law (2022)
  • The Best Lawyers in America©, Health Care Law (2025)

Credentials

Education

  • Northwestern Pritzker School of Law (J.D., cum laude, 2004)
  • University of Arizona (B.S., magna cum laude, 1996)
    • Microbiology

Bar Admissions

  • Illinois

Court Admissions

  • U.S. District Court, Northern District of Illinois

Professional & Community Involvement

  • American Health Lawyers Association
  • Life Sciences Law 360 Editorial Board (2015 to 2017)

Media

Events

Insights

View All Insights

Insights

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.